Stem Cell Therapeutics Corp. Announces Q2 2011 Financial Results, Election of Board of Directors and Management Appointment

CALGARY, ALBERTA — Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) (“SCT” or the “Company”) today announced its results for the period ended June 30, 2011. The Company’s loss for the six month period ended June 30, 2011 decreased by $1,851,163 …

[Read the full article here]

Comments are closed.